Jennifer Orchard

1.0k total citations
16 papers, 742 citations indexed

About

Jennifer Orchard is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Jennifer Orchard has authored 16 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 10 papers in Pathology and Forensic Medicine and 6 papers in Immunology. Recurrent topics in Jennifer Orchard's work include Chronic Lymphocytic Leukemia Research (13 papers), Lymphoma Diagnosis and Treatment (10 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Jennifer Orchard is often cited by papers focused on Chronic Lymphocytic Leukemia Research (13 papers), Lymphoma Diagnosis and Treatment (10 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Jennifer Orchard collaborates with scholars based in United Kingdom, Australia and Canada. Jennifer Orchard's co-authors include David Oscier, Freda K. Stevenson, Zadie Davis, Terry J. Hamblin, Amy S. Gardiner, Rachel Ibbotson, A. G. Prentice, Han Myint, J. A. Copplestone and M. Hamon and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Oncogene.

In The Last Decade

Jennifer Orchard

16 papers receiving 713 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer Orchard United Kingdom 12 590 435 286 145 99 16 742
Zoltán Mátrai Hungary 10 429 0.7× 289 0.7× 214 0.7× 75 0.5× 140 1.4× 30 561
Thomas M. Jahn United States 11 636 1.1× 437 1.0× 219 0.8× 204 1.4× 236 2.4× 22 743
Maurice Navarro France 6 357 0.6× 320 0.7× 187 0.7× 94 0.6× 59 0.6× 13 500
Daniel Heintel Austria 13 346 0.6× 289 0.7× 168 0.6× 322 2.2× 442 4.5× 30 846
Nilima Parry‐Jones United Kingdom 13 319 0.5× 318 0.7× 100 0.3× 61 0.4× 95 1.0× 21 500
Gaetano Vitelli Italy 14 298 0.5× 158 0.4× 154 0.5× 130 0.9× 308 3.1× 28 673
Kerstin Allen United States 13 467 0.8× 472 1.1× 248 0.9× 116 0.8× 261 2.6× 18 754
H Urbańska-Ryś Poland 12 197 0.3× 156 0.4× 99 0.3× 133 0.9× 111 1.1× 24 449
Jean Luc Harousseau France 11 168 0.3× 132 0.3× 78 0.3× 433 3.0× 365 3.7× 21 636
Shulamiet Wittebol Netherlands 15 159 0.3× 166 0.4× 100 0.3× 493 3.4× 384 3.9× 33 791

Countries citing papers authored by Jennifer Orchard

Since Specialization
Citations

This map shows the geographic impact of Jennifer Orchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Orchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Orchard more than expected).

Fields of papers citing papers by Jennifer Orchard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Orchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Orchard. The network helps show where Jennifer Orchard may publish in the future.

Co-authorship network of co-authors of Jennifer Orchard

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Orchard. A scholar is included among the top collaborators of Jennifer Orchard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Orchard. Jennifer Orchard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Best, Giles, Rachel Ibbotson, Anton Parker, et al.. (2006). ZAP‐70 by flow cytometry: A comparison of different antibodies, anticoagulants, and methods of analysis. Cytometry Part B Clinical Cytometry. 70B(4). 235–241. 27 indexed citations
2.
Potter, Kathleen N., C. Ian Mockridge, Isla Wheatley, et al.. (2006). Structural and Functional Features of the B-Cell Receptor in IgG-Positive Chronic Lymphocytic Leukemia. Clinical Cancer Research. 12(6). 1672–1679. 28 indexed citations
3.
Catovsky, Daniel, Estella Matutes, Alison Morilla, et al.. (2004). Gender as a Prognostic Factor in CLL. Biological Pointers to the Improved Outcome of Women.. Blood. 104(11). 957–957. 6 indexed citations
4.
Ibbotson, Rachel, Jennifer Orchard, Anne Gardiner, et al.. (2003). P2X7 polymorphism and chronic lymphocytic leukaemia: lack of correlation with incidence, survival and abnormalities of chromosome 12. Leukemia. 17(11). 2097–2100. 42 indexed citations
5.
Zhu, Delin, Jennifer Orchard, David Oscier, Dennis H. Wright, & Freda K. Stevenson. (2002). V H gene analysis of splenic marginal zone lymphomas reveals diversity in mutational status and initiation of somatic mutation in vivo. Blood. 100(7). 2659–2661. 27 indexed citations
6.
Oscier, David, Jennifer Orchard, Dominic Culligan, et al.. (2001). The bioavailability of oral fludarabine phosphate is unaffected by food. The Hematology Journal. 2(5). 316–321. 26 indexed citations
7.
Hamblin, Terry J., Jennifer Orchard, Amy S. Gardiner, et al.. (2000). Immunoglobulin V genes and CD38 expression in CLL. Blood. 95(7). 2455–2457. 103 indexed citations
8.
Hamblin, Terry J., Jennifer Orchard, Amy S. Gardiner, et al.. (2000). Immunoglobulin V genes and CD38 expression in CLL. Blood. 95(7). 2455–2457. 126 indexed citations
9.
Foran, James M., David Oscier, Jennifer Orchard, et al.. (1999). Pharmacokinetic Study of Single Doses of Oral Fludarabine Phosphate in Patients With “Low-Grade” Non-Hodgkin's Lymphoma and B-Cell Chronic Lymphocytic Leukemia. Journal of Clinical Oncology. 17(5). 1574–1574. 52 indexed citations
10.
Bosanquet, Andrew G., et al.. (1999). Response to cladribine in previously treated patients with chronic lymphocytic leukaemia identified by ex vivo assessment of drug sensitivity by DiSC assay. British Journal of Haematology. 106(2). 474–476. 11 indexed citations
11.
Corcoran, Martin, Sarah Mould, Jennifer Orchard, et al.. (1999). Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations. Oncogene. 18(46). 6271–6277. 108 indexed citations
12.
Myint, Han, David Oscier, Jennifer Orchard, et al.. (1998). Autoimmune Haemolysis in Patients with B-CLL Treated with Chlorodeoxyadenosine (CDA). Leukemia & lymphoma. 29(3-4). 391–398. 23 indexed citations
13.
Myint, Han, J. A. Copplestone, Jennifer Orchard, et al.. (1995). Fludarabine‐related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia. British Journal of Haematology. 91(2). 341–344. 133 indexed citations
14.
Standen, Graham R., Jennifer Orchard, & Richard D. Hutton. (1990). Wiskott‐Aldrich syndrome: fatal consequences of splenectomy in an unrecognised attenuated variant. International Journal of Clinical Practice. 44(8). 338–339. 5 indexed citations
15.
Orchard, Jennifer, et al.. (1990). Severe Intravascular Haemolysis in a Renal Transplant Recipient due to Anti‐B of Donor Origin. Vox Sanguinis. 59(3). 172–175. 14 indexed citations
16.
Hutton, Richard D., et al.. (1987). Polycythaemia following Renal Transplantation: An Association with Azathioprine Dosage?. American Journal of Nephrology. 7(3). 221–225. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026